483 related articles for article (PubMed ID: 20952497)
1. Signaling pathways leading to phosphorylation of Akt and GSK-3β by activation of cloned human and rat cerebral D₂and D₃ receptors.
Mannoury la Cour C; Salles MJ; Pasteau V; Millan MJ
Mol Pharmacol; 2011 Jan; 79(1):91-105. PubMed ID: 20952497
[TBL] [Abstract][Full Text] [Related]
2. Transient and rapid activation of Akt/GSK-3β and mTORC1 signaling by D3 dopamine receptor stimulation in dorsal striatum and nucleus accumbens.
Salles MJ; Hervé D; Rivet JM; Longueville S; Millan MJ; Girault JA; Mannoury la Cour C
J Neurochem; 2013 May; 125(4):532-44. PubMed ID: 23410496
[TBL] [Abstract][Full Text] [Related]
3. Regulation of PI3K/Akt signaling by N-desmethylclozapine through activation of δ-opioid receptor.
Olianas MC; Dedoni S; Onali P
Eur J Pharmacol; 2011 Jun; 660(2-3):341-50. PubMed ID: 21515255
[TBL] [Abstract][Full Text] [Related]
4. Signaling pathways mediating phosphorylation and inactivation of glycogen synthase kinase-3β by the recombinant human δ-opioid receptor stably expressed in Chinese hamster ovary cells.
Olianas MC; Dedoni S; Onali P
Neuropharmacology; 2011 Jun; 60(7-8):1326-36. PubMed ID: 21276805
[TBL] [Abstract][Full Text] [Related]
5. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.
Millan MJ; Cussac D; Gobert A; Lejeune F; Rivet JM; Mannoury La Cour C; Newman-Tancredi A; Peglion JL
J Pharmacol Exp Ther; 2004 Jun; 309(3):903-20. PubMed ID: 14978194
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus.
Castorina A; D'Amico AG; Scuderi S; Leggio GM; Drago F; D'Agata V
Neuroscience; 2013 Oct; 250():546-56. PubMed ID: 23906635
[TBL] [Abstract][Full Text] [Related]
8. Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses.
Nair VD; Olanow CW
J Biol Chem; 2008 May; 283(22):15469-78. PubMed ID: 18387957
[TBL] [Abstract][Full Text] [Related]
9. The Akt/GSK-3beta axis as a new signaling pathway of the histamine H(3) receptor.
Bongers G; Sallmen T; Passani MB; Mariottini C; Wendelin D; Lozada A; Marle Av; Navis M; Blandina P; Bakker RA; Panula P; Leurs R
J Neurochem; 2007 Oct; 103(1):248-58. PubMed ID: 17623045
[TBL] [Abstract][Full Text] [Related]
10. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma.
Khor TO; Gul YA; Ithnin H; Seow HF
Cancer Lett; 2004 Jul; 210(2):139-50. PubMed ID: 15183529
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia.
Amar S; Shaltiel G; Mann L; Shamir A; Dean B; Scarr E; Bersudsky Y; Belmaker RH; Agam G
Int J Neuropsychopharmacol; 2008 Mar; 11(2):197-205. PubMed ID: 17681085
[TBL] [Abstract][Full Text] [Related]
12. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole.
Millan MJ; Di Cara B; Hill M; Jackson M; Joyce JN; Brotchie J; McGuire S; Crossman A; Smith L; Jenner P; Gobert A; Peglion JL; Brocco M
J Pharmacol Exp Ther; 2004 Jun; 309(3):921-35. PubMed ID: 14978195
[TBL] [Abstract][Full Text] [Related]
13. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection induced by sevoflurane-delayed post-conditioning is attributable to increased phosphorylation of mitochondrial GSK-3β through the PI3K/Akt survival pathway.
Ye Z; Xia P; Cheng ZG; Guo Q
J Neurol Sci; 2015 Jan; 348(1-2):216-25. PubMed ID: 25555490
[TBL] [Abstract][Full Text] [Related]
15. GSK-3beta regulation in skeletal muscles by adrenaline and insulin: evidence that PKA and PKB regulate different pools of GSK-3.
Jensen J; Brennesvik EO; Lai YC; Shepherd PR
Cell Signal; 2007 Jan; 19(1):204-10. PubMed ID: 16934435
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of insulin-induced PI3K/Akt/GSK-3beta and ERK signaling by neuronal nicotinic receptor/PKC-alpha/ERK pathway: up-regulation of IRS-1/-2 mRNA and protein in adrenal chromaffin cells.
Sugano T; Yanagita T; Yokoo H; Satoh S; Kobayashi H; Wada A
J Neurochem; 2006 Jul; 98(1):20-33. PubMed ID: 16805793
[TBL] [Abstract][Full Text] [Related]
17. S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.
Millan MJ; Gobert A; Newman-Tancredi A; Lejeune F; Cussac D; Rivet JM; Audinot V; Dubuffet T; Lavielle G
J Pharmacol Exp Ther; 2000 Jun; 293(3):1048-62. PubMed ID: 10869410
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3beta in irradiated vascular endothelium.
Tan J; Geng L; Yazlovitskaya EM; Hallahan DE
Cancer Res; 2006 Feb; 66(4):2320-7. PubMed ID: 16489037
[TBL] [Abstract][Full Text] [Related]
19. α-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt/GSK-3β signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia.
Deslauriers J; Desmarais C; Sarret P; Grignon S
J Mol Neurosci; 2013 May; 50(1):134-45. PubMed ID: 22975849
[TBL] [Abstract][Full Text] [Related]
20. Akt mediates GSK-3β phosphorylation in the rat prefrontal cortex during the process of ketamine exerting rapid antidepressant actions.
Zhou W; Dong L; Wang N; Shi JY; Yang JJ; Zuo ZY; Zhou ZQ
Neuroimmunomodulation; 2014; 21(4):183-8. PubMed ID: 24504086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]